Clinical trial
Discovery of Bioactive Compounds as Agonists of GLP1 Receptor for Obesity Treatment
NCT06513715 is registered in ClinicalTrials.gov with Universidad Católica San Antonio de Murcia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Discovery of Bioactive Compounds as Agonists of GLP1 Receptor for Obesity Treatment
- Lead sponsor
- Universidad Católica San Antonio de Murcia
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 9, 2024
- Completion date
- July 1, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.